Flutialfa F 250 Capsule is a combination medication designed to manage asthma and chronic obstructive pulmonary disease (COPD). It contains Fluticasone Propionate, a potent corticosteroid, and Formoterol Fumarate, a long-acting beta-agonist (LABA). Together, these ingredients provide dual benefits by reducing inflammation in the airways and improving airflow, making breathing easier for individuals with respiratory conditions.
Fluticasone Propionate works by reducing inflammation, swelling, and mucus production in the airways, preventing asthma attacks and COPD flare-ups. Formoterol Fumarate, as a bronchodilator, relaxes the muscles around the airways, allowing for easier air passage and long-term relief of symptoms like wheezing, shortness of breath, and chest tightness.
This combination medication is designed to be taken once daily in capsule form, providing long-lasting symptom relief and improving the quality of life for patients with chronic respiratory conditions. The Life Cap technology ensures effective and consistent drug delivery to the lungs, optimizing the therapeutic action of both ingredients.
Flutialfa F 250 Capsule helps to control asthma symptoms and prevent exacerbations in patients who require both anti-inflammatory treatment and bronchodilation. It is not intended for the relief of acute asthma attacks but is used regularly for long-term control.